KNC LaboratoriesKNC Laboratories Co., Ltd.6568東証グロースサービス業FY ending Mar 2026, non-consolidated, J-GAAP

KNC Laboratories FY ending Mar 2020 results

KNC Laboratories brought in ¥6.35B in revenue.

Out of every ¥100 of sales, about ¥9 is left as operating profit.

Where the money goes

For every ¥100 KNC Laboratories sells, how much goes where, and how much is kept.

FY ending Mar 2020

Margin funnel (derived from reported values)Gross margin 27.3% → Operating margin 9.1% → Net margin 8.2%

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第40期(2023/04/01－2024/03/31)
ID S100TBRY2024-06-26Open
EDINET (FSA Japan)
有価証券報告書－第38期(令和3年4月1日－令和4年3月31日)
ID S100O66A2022-06-24Open
EDINET (FSA Japan)
有価証券報告書－第37期(令和2年4月1日－令和3年3月31日)
ID S100LELI2021-06-25Open

Extracted from XBRL: 42 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.